Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 80 entries
Sorted by: Best Match Show Resources per page
Computerised versus conventional methodology of radiographic joint destruction assessment in early rheumatoid arthritis.

RMD open

Huo Y, De Hair MJ, Shaib YO, van der Heijde D, Kuchuk NO, Viergever MA, van Laar JM, Vincken KL, Lafeber FP.
PMID: 26688750
RMD Open. 2015 Dec 09;1(1):e000148. doi: 10.1136/rmdopen-2015-000148. eCollection 2015.

OBJECTIVES: To compare computerised and conventional methodology of radiographic joint destruction assessment in early rheumatoid arthritis (RA).METHODS: We investigated the contribution of the 3rd-to-5th carpometacarpal joints (CMC3-5, which are excluded in computerised assessment so far owing to bone overlapping)...

Cite
Huo Y, De Hair MJ, Shaib YO, et al. Computerised versus conventional methodology of radiographic joint destruction assessment in early rheumatoid arthritis. RMD Open. 2015;1(1):e000148doi: 10.1136/rmdopen-2015-000148.
Huo, Y., De Hair, M. J., Shaib, Y. O., van der Heijde, D., Kuchuk, N. O., Viergever, M. A., van Laar, J. M., Vincken, K. L., & Lafeber, F. P. (2015). Computerised versus conventional methodology of radiographic joint destruction assessment in early rheumatoid arthritis. RMD open, 1(1), e000148. https://doi.org/10.1136/rmdopen-2015-000148
Huo, Yinghe, et al. "Computerised versus conventional methodology of radiographic joint destruction assessment in early rheumatoid arthritis." RMD open vol. 1,1 (2015): e000148. doi: https://doi.org/10.1136/rmdopen-2015-000148
Huo Y, De Hair MJ, Shaib YO, van der Heijde D, Kuchuk NO, Viergever MA, van Laar JM, Vincken KL, Lafeber FP. Computerised versus conventional methodology of radiographic joint destruction assessment in early rheumatoid arthritis. RMD Open. 2015 Dec 09;1(1):e000148. doi: 10.1136/rmdopen-2015-000148. eCollection 2015. PMID: 26688750; PMCID: PMC4680585.
Copy Download .nbib Format: NLM
NAFLD Phenotype in Patients With V-ATPase Proton Pump Assembly Defects.

Cellular and molecular gastroenterology and hepatology

Jansen JC, Wolthuis D, Van Scherpenzeel M, Ratziu V, Drenth JPH, Lefeber DJ.
PMID: 29675453
Cell Mol Gastroenterol Hepatol. 2018 Jan 18;5(3):415-417.e1. doi: 10.1016/j.jcmgh.2017.12.011. eCollection 2018 Mar.

No abstract available.

Cite
Jansen JC, Wolthuis D, Van Scherpenzeel M, et al. NAFLD Phenotype in Patients With V-ATPase Proton Pump Assembly Defects. Cell Mol Gastroenterol Hepatol. 2018;5(3):415-417.e1doi: 10.1016/j.jcmgh.2017.12.011.
Jansen, J. C., Wolthuis, D., Van Scherpenzeel, M., Ratziu, V., Drenth, J. P. H., & Lefeber, D. J. (2018). NAFLD Phenotype in Patients With V-ATPase Proton Pump Assembly Defects. Cellular and molecular gastroenterology and hepatology, 5(3), 415-417.e1. https://doi.org/10.1016/j.jcmgh.2017.12.011
Jansen, Jos C, et al. "NAFLD Phenotype in Patients With V-ATPase Proton Pump Assembly Defects." Cellular and molecular gastroenterology and hepatology vol. 5,3 (2018): 415-417.e1. doi: https://doi.org/10.1016/j.jcmgh.2017.12.011
Jansen JC, Wolthuis D, Van Scherpenzeel M, Ratziu V, Drenth JPH, Lefeber DJ. NAFLD Phenotype in Patients With V-ATPase Proton Pump Assembly Defects. Cell Mol Gastroenterol Hepatol. 2018 Jan 18;5(3):415-417.e1. doi: 10.1016/j.jcmgh.2017.12.011. eCollection 2018 Mar. PMID: 29675453; PMCID: PMC5904036.
Copy Download .nbib Format: NLM
An Unexplained Congenital Disorder of Glycosylation-II in a Child with Neurohepatic Involvement, Hypercholesterolemia and Hypoceruloplasminemia.

JIMD reports

Calvo PL, Spada M, Rabbone I, Pinon M, Porta F, Cisarò F, Reggiani S, Cefalù AB, Sturiale L, Garozzo D, Lefeber DJ, Jaeken J.
PMID: 28643274
JIMD Rep. 2018;38:97-100. doi: 10.1007/8904_2017_35. Epub 2017 Jun 23.

We report on a 12-year-old adopted boy with psychomotor disability, absence seizures, and normal brain MRI. He showed increased (but initially, at 5 months, normal) serum cholesterol, increased alkaline phosphatases, transiently increased transaminases and hypoceruloplasminemia with normal serum and...

Cite
Calvo PL, Spada M, Rabbone I, et al. An Unexplained Congenital Disorder of Glycosylation-II in a Child with Neurohepatic Involvement, Hypercholesterolemia and Hypoceruloplasminemia. JIMD Rep. 2017;38:97-100doi: 10.1007/8904_2017_35.
Calvo, P. L., Spada, M., Rabbone, I., Pinon, M., Porta, F., Cisarò, F., Reggiani, S., Cefalù, A. B., Sturiale, L., Garozzo, D., Lefeber, D. J., & Jaeken, J. (2018). An Unexplained Congenital Disorder of Glycosylation-II in a Child with Neurohepatic Involvement, Hypercholesterolemia and Hypoceruloplasminemia. JIMD reports, 3897-100. https://doi.org/10.1007/8904_2017_35
Calvo, Pier Luigi, et al. "An Unexplained Congenital Disorder of Glycosylation-II in a Child with Neurohepatic Involvement, Hypercholesterolemia and Hypoceruloplasminemia." JIMD reports vol. 38 (2018): 97-100. doi: https://doi.org/10.1007/8904_2017_35
Calvo PL, Spada M, Rabbone I, Pinon M, Porta F, Cisarò F, Reggiani S, Cefalù AB, Sturiale L, Garozzo D, Lefeber DJ, Jaeken J. An Unexplained Congenital Disorder of Glycosylation-II in a Child with Neurohepatic Involvement, Hypercholesterolemia and Hypoceruloplasminemia. JIMD Rep. 2018;38:97-100. doi: 10.1007/8904_2017_35. Epub 2017 Jun 23. PMID: 28643274; PMCID: PMC5874206.
Copy Download .nbib Format: NLM
Five-Year Follow-up of Knee Joint Distraction: Clinical Benefit and Cartilaginous Tissue Repair in an Open Uncontrolled Prospective Study.

Cartilage

van der Woude JAD, Wiegant K, van Roermund PM, Intema F, Custers RJH, Eckstein F, van Laar JM, Mastbergen SC, Lafeber FPJG.
PMID: 28618871
Cartilage. 2017 Jul;8(3):263-271. doi: 10.1177/1947603516665442. Epub 2016 Aug 26.

Objective In end-stage knee osteoarthritis, total knee arthroplasty (TKA) may finally become inevitable. At a relatively young age, this comes with the risk of future revision surgery. Therefore, in these cases, joint preserving surgery such as knee joint distraction...

Cite
van der Woude JAD, Wiegant K, van Roermund PM, et al. Five-Year Follow-up of Knee Joint Distraction: Clinical Benefit and Cartilaginous Tissue Repair in an Open Uncontrolled Prospective Study. Cartilage. 2016;8(3):263-271doi: 10.1177/1947603516665442.
van der Woude, J. A. D., Wiegant, K., van Roermund, P. M., Intema, F., Custers, R. J. H., Eckstein, F., van Laar, J. M., Mastbergen, S. C., & Lafeber, F. P. J. G. (2017). Five-Year Follow-up of Knee Joint Distraction: Clinical Benefit and Cartilaginous Tissue Repair in an Open Uncontrolled Prospective Study. Cartilage, 8(3), 263-271. https://doi.org/10.1177/1947603516665442
van der Woude, Jan-Ton A D, et al. "Five-Year Follow-up of Knee Joint Distraction: Clinical Benefit and Cartilaginous Tissue Repair in an Open Uncontrolled Prospective Study." Cartilage vol. 8,3 (2017): 263-271. doi: https://doi.org/10.1177/1947603516665442
van der Woude JAD, Wiegant K, van Roermund PM, Intema F, Custers RJH, Eckstein F, van Laar JM, Mastbergen SC, Lafeber FPJG. Five-Year Follow-up of Knee Joint Distraction: Clinical Benefit and Cartilaginous Tissue Repair in an Open Uncontrolled Prospective Study. Cartilage. 2017 Jul;8(3):263-271. doi: 10.1177/1947603516665442. Epub 2016 Aug 26. PMID: 28618871; PMCID: PMC5625862.
Copy Download .nbib Format: NLM
A mutation in mannose-phosphate-dolichol utilization defect 1 reveals clinical symptoms of congenital disorders of glycosylation type I and dystroglycanopathy.

JIMD reports

van Tol W, Ashikov A, Korsch E, Abu Bakar N, Willemsen MA, Thiel C, Lefeber DJ.
PMID: 31741824
JIMD Rep. 2019 Sep 30;50(1):31-39. doi: 10.1002/jmd2.12060. eCollection 2019 Nov.

Congenital disorders of glycosylation type I (CDG-I) are inborn errors of metabolism, generally characterized by multisystem clinical manifestations, including developmental delay, hepatopathy, hypotonia, and skin, skeletal, and neurological abnormalities. Among others, dolichol-phosphate-mannose (DPM) is the mannose donor for N-glycosylation...

Cite
van Tol W, Ashikov A, Korsch E, et al. A mutation in mannose-phosphate-dolichol utilization defect 1 reveals clinical symptoms of congenital disorders of glycosylation type I and dystroglycanopathy. JIMD Rep. 2019;50(1):31-39doi: 10.1002/jmd2.12060.
van Tol, W., Ashikov, A., Korsch, E., Abu Bakar, N., Willemsen, M. A., Thiel, C., & Lefeber, D. J. (2019). A mutation in mannose-phosphate-dolichol utilization defect 1 reveals clinical symptoms of congenital disorders of glycosylation type I and dystroglycanopathy. JIMD reports, 50(1), 31-39. https://doi.org/10.1002/jmd2.12060
van Tol, Walinka, et al. "A mutation in mannose-phosphate-dolichol utilization defect 1 reveals clinical symptoms of congenital disorders of glycosylation type I and dystroglycanopathy." JIMD reports vol. 50,1 (2019): 31-39. doi: https://doi.org/10.1002/jmd2.12060
van Tol W, Ashikov A, Korsch E, Abu Bakar N, Willemsen MA, Thiel C, Lefeber DJ. A mutation in mannose-phosphate-dolichol utilization defect 1 reveals clinical symptoms of congenital disorders of glycosylation type I and dystroglycanopathy. JIMD Rep. 2019 Sep 30;50(1):31-39. doi: 10.1002/jmd2.12060. eCollection 2019 Nov. PMID: 31741824; PMCID: PMC6850978.
Copy Download .nbib Format: NLM
Loss of the AMD-associated B3GLCT gene affects glycosylation of TSP1 without impairing secretion in retinal pigment epithelial cells.

Experimental eye research

Lauwen S, Baerenfaenger M, Ruigrok S, de Jong EK, Wessels HJCT, den Hollander AI, Lefeber DJ.
PMID: 34695439
Exp Eye Res. 2021 Dec;213:108798. doi: 10.1016/j.exer.2021.108798. Epub 2021 Oct 22.

Age-related macular degeneration (AMD) has been associated with protective genetic variants in the β1-3 glucosyltransferase (B3GLCT) locus through genome-wide association studies. B3GLCT mediates modification of proteins with thrombospondin type I repeats (TSR) that contain O-linked glucose β1-3 fucose and...

Cite
Lauwen S, Baerenfaenger M, Ruigrok S, et al. Loss of the AMD-associated B3GLCT gene affects glycosylation of TSP1 without impairing secretion in retinal pigment epithelial cells. Exp Eye Res. 2021;213:108798doi: 10.1016/j.exer.2021.108798.
Lauwen, S., Baerenfaenger, M., Ruigrok, S., de Jong, E. K., Wessels, H. J. C. T., den Hollander, A. I., & Lefeber, D. J. (2021). Loss of the AMD-associated B3GLCT gene affects glycosylation of TSP1 without impairing secretion in retinal pigment epithelial cells. Experimental eye research, 213108798. https://doi.org/10.1016/j.exer.2021.108798
Lauwen, Susette, et al. "Loss of the AMD-associated B3GLCT gene affects glycosylation of TSP1 without impairing secretion in retinal pigment epithelial cells." Experimental eye research vol. 213 (2021): 108798. doi: https://doi.org/10.1016/j.exer.2021.108798
Lauwen S, Baerenfaenger M, Ruigrok S, de Jong EK, Wessels HJCT, den Hollander AI, Lefeber DJ. Loss of the AMD-associated B3GLCT gene affects glycosylation of TSP1 without impairing secretion in retinal pigment epithelial cells. Exp Eye Res. 2021 Dec;213:108798. doi: 10.1016/j.exer.2021.108798. Epub 2021 Oct 22. PMID: 34695439.
Copy Download .nbib Format: NLM
Defective Lipid Droplet-Lysosome Interaction Causes Fatty Liver Disease as Evidenced by Human Mutations in TMEM199 and CCDC115.

Cellular and molecular gastroenterology and hepatology

Larsen LE, van den Boogert MAW, Rios-Ocampo WA, Jansen JC, Conlon D, Chong PLE, Levels JHM, Eilers RE, Sachdev VV, Zelcer N, Raabe T, He M, Hand NJ, Drenth JPH, Rader DJ, Stroes ESG, Lefeber DJ, Jonker JW, Holleboom AG.
PMID: 34626841
Cell Mol Gastroenterol Hepatol. 2021 Oct 07;13(2):583-597. doi: 10.1016/j.jcmgh.2021.09.013. Epub 2021 Oct 07.

BACKGROUND & AIMS: Recently, novel inborn errors of metabolism were identified because of mutations in V-ATPase assembly factors TMEM199 and CCDC115. Patients are characterized by generalized protein glycosylation defects, hypercholesterolemia, and fatty liver disease. Here, we set out to...

Cite
Larsen LE, van den Boogert MAW, Rios-Ocampo WA, et al. Defective Lipid Droplet-Lysosome Interaction Causes Fatty Liver Disease as Evidenced by Human Mutations in TMEM199 and CCDC115. Cell Mol Gastroenterol Hepatol. 2021;13(2):583-597doi: 10.1016/j.jcmgh.2021.09.013.
Larsen, L. E., van den Boogert, M. A. W., Rios-Ocampo, W. A., Jansen, J. C., Conlon, D., Chong, P. L. E., Levels, J. H. M., Eilers, R. E., Sachdev, V. V., Zelcer, N., Raabe, T., He, M., Hand, N. J., Drenth, J. P. H., Rader, D. J., Stroes, E. S. G., Lefeber, D. J., Jonker, J. W., & Holleboom, A. G. (2021). Defective Lipid Droplet-Lysosome Interaction Causes Fatty Liver Disease as Evidenced by Human Mutations in TMEM199 and CCDC115. Cellular and molecular gastroenterology and hepatology, 13(2), 583-597. https://doi.org/10.1016/j.jcmgh.2021.09.013
Larsen, Lars E, et al. "Defective Lipid Droplet-Lysosome Interaction Causes Fatty Liver Disease as Evidenced by Human Mutations in TMEM199 and CCDC115." Cellular and molecular gastroenterology and hepatology vol. 13,2 (2021): 583-597. doi: https://doi.org/10.1016/j.jcmgh.2021.09.013
Larsen LE, van den Boogert MAW, Rios-Ocampo WA, Jansen JC, Conlon D, Chong PLE, Levels JHM, Eilers RE, Sachdev VV, Zelcer N, Raabe T, He M, Hand NJ, Drenth JPH, Rader DJ, Stroes ESG, Lefeber DJ, Jonker JW, Holleboom AG. Defective Lipid Droplet-Lysosome Interaction Causes Fatty Liver Disease as Evidenced by Human Mutations in TMEM199 and CCDC115. Cell Mol Gastroenterol Hepatol. 2021 Oct 07;13(2):583-597. doi: 10.1016/j.jcmgh.2021.09.013. Epub 2021 Oct 07. PMID: 34626841.
Copy Download .nbib Format: NLM
Is tocilizumab monotherapy as effective in preventing radiographic progression in rheumatoid arthritis as its combination with methotrexate?.

Arthritis care & research

Verhoeven MMA, Tekstra J, Jacobs JWG, Bijlsma JWJ, van Laar JM, Pethö-Schramm A, Borm MEA, Lafeber FPJ, Welsing PMJ.
PMID: 33253497
Arthritis Care Res (Hoboken). 2020 Nov 30; doi: 10.1002/acr.24524. Epub 2020 Nov 30.

OBJECTIVE: To compare the effect of preventing radiographic progression (in its 3 components) of tocilizumab (TCZ) monotherapy with those of TCZ combined with methotrexate (TCZ+MTX), and to evaluate possible effect modifiers.METHODS: Randomized trials comparing TCZ-monotherapy with TCZ+MTX combination therapy...

Cite
Verhoeven MMA, Tekstra J, Jacobs JWG, et al. Is tocilizumab monotherapy as effective in preventing radiographic progression in rheumatoid arthritis as its combination with methotrexate?. Arthritis Care Res (Hoboken). 2020;doi: 10.1002/acr.24524.
Verhoeven, M. M. A., Tekstra, J., Jacobs, J. W. G., Bijlsma, J. W. J., van Laar, J. M., Pethö-Schramm, A., Borm, M. E. A., Lafeber, F. P. J., & Welsing, P. M. J. (2020). Is tocilizumab monotherapy as effective in preventing radiographic progression in rheumatoid arthritis as its combination with methotrexate?. Arthritis care & research, . https://doi.org/10.1002/acr.24524
Verhoeven, Maxime M A, et al. "Is tocilizumab monotherapy as effective in preventing radiographic progression in rheumatoid arthritis as its combination with methotrexate?." Arthritis care & research vol. (2020). doi: https://doi.org/10.1002/acr.24524
Verhoeven MMA, Tekstra J, Jacobs JWG, Bijlsma JWJ, van Laar JM, Pethö-Schramm A, Borm MEA, Lafeber FPJ, Welsing PMJ. Is tocilizumab monotherapy as effective in preventing radiographic progression in rheumatoid arthritis as its combination with methotrexate?. Arthritis Care Res (Hoboken). 2020 Nov 30; doi: 10.1002/acr.24524. Epub 2020 Nov 30. PMID: 33253497.
Copy Download .nbib Format: NLM
Gene Expression Signatures of Synovial Fluid Multipotent Stromal Cells in Advanced Knee Osteoarthritis and Following Knee Joint Distraction.

Frontiers in bioengineering and biotechnology

Sanjurjo-Rodriguez C, Altaie A, Mastbergen S, Baboolal T, Welting T, Lafeber F, Pandit H, McGonagle D, Jones E.
PMID: 33178674
Front Bioeng Biotechnol. 2020 Oct 14;8:579751. doi: 10.3389/fbioe.2020.579751. eCollection 2020.

Osteoarthritis (OA) is the most common musculoskeletal disorder. Although joint replacement remains the standard of care for knee OA patients, knee joint distraction (KJD), which works by temporarily off-loading the joint for 6-8 weeks, is becoming a novel joint-sparing...

Cite
Sanjurjo-Rodriguez C, Altaie A, Mastbergen S, et al. Gene Expression Signatures of Synovial Fluid Multipotent Stromal Cells in Advanced Knee Osteoarthritis and Following Knee Joint Distraction. Front Bioeng Biotechnol. 2020;8:579751doi: 10.3389/fbioe.2020.579751.
Sanjurjo-Rodriguez, C., Altaie, A., Mastbergen, S., Baboolal, T., Welting, T., Lafeber, F., Pandit, H., McGonagle, D., & Jones, E. (2020). Gene Expression Signatures of Synovial Fluid Multipotent Stromal Cells in Advanced Knee Osteoarthritis and Following Knee Joint Distraction. Frontiers in bioengineering and biotechnology, 8579751. https://doi.org/10.3389/fbioe.2020.579751
Sanjurjo-Rodriguez, Clara, et al. "Gene Expression Signatures of Synovial Fluid Multipotent Stromal Cells in Advanced Knee Osteoarthritis and Following Knee Joint Distraction." Frontiers in bioengineering and biotechnology vol. 8 (2020): 579751. doi: https://doi.org/10.3389/fbioe.2020.579751
Sanjurjo-Rodriguez C, Altaie A, Mastbergen S, Baboolal T, Welting T, Lafeber F, Pandit H, McGonagle D, Jones E. Gene Expression Signatures of Synovial Fluid Multipotent Stromal Cells in Advanced Knee Osteoarthritis and Following Knee Joint Distraction. Front Bioeng Biotechnol. 2020 Oct 14;8:579751. doi: 10.3389/fbioe.2020.579751. eCollection 2020. PMID: 33178674; PMCID: PMC7591809.
Copy Download .nbib Format: NLM
IL4-10 Fusion Protein Shows DMOAD Activity in a Rat Osteoarthritis Model.

Cartilage

van Helvoort EM, de Visser HM, Lafeber FPJG, Coeleveld K, Versteeg S, Weinans HH, Popov-Celeketic J, Eijkelkamp N, Mastbergen SC.
PMID: 34159843
Cartilage. 2021 Dec;13(2):1155S-1164S. doi: 10.1177/19476035211026736. Epub 2021 Jun 23.

OBJECTIVE: Ideally, disease-modifying osteoarthritis (OA) drugs (DMOAD) should combine chondroprotective, anti-inflammatory, and analgesic effects in a single molecule. A fusion protein of interleukin-4 (IL-4) and IL-10 (IL4-10 FP) possesses these combined effects. In this study, the DMOAD activity of...

Cite
van Helvoort EM, de Visser HM, Lafeber FPJG, et al. IL4-10 Fusion Protein Shows DMOAD Activity in a Rat Osteoarthritis Model. Cartilage. 2021;13(2):1155S-1164Sdoi: 10.1177/19476035211026736.
van Helvoort, E. M., de Visser, H. M., Lafeber, F. P. J. G., Coeleveld, K., Versteeg, S., Weinans, H. H., Popov-Celeketic, J., Eijkelkamp, N., & Mastbergen, S. C. (2021). IL4-10 Fusion Protein Shows DMOAD Activity in a Rat Osteoarthritis Model. Cartilage, 13(2), 1155S-1164S. https://doi.org/10.1177/19476035211026736
van Helvoort, E M, et al. "IL4-10 Fusion Protein Shows DMOAD Activity in a Rat Osteoarthritis Model." Cartilage vol. 13,2 (2021): 1155S-1164S. doi: https://doi.org/10.1177/19476035211026736
van Helvoort EM, de Visser HM, Lafeber FPJG, Coeleveld K, Versteeg S, Weinans HH, Popov-Celeketic J, Eijkelkamp N, Mastbergen SC. IL4-10 Fusion Protein Shows DMOAD Activity in a Rat Osteoarthritis Model. Cartilage. 2021 Dec;13(2):1155S-1164S. doi: 10.1177/19476035211026736. Epub 2021 Jun 23. PMID: 34159843.
Copy Download .nbib Format: NLM
Defective Lipid Droplet-Lysosome Interaction Causes Fatty Liver Disease as Evidenced by Human Mutations in TMEM199 and CCDC115.

Cellular and molecular gastroenterology and hepatology

Larsen LE, van den Boogert MAW, Rios-Ocampo WA, Jansen JC, Conlon D, Chong PLE, Levels JHM, Eilers RE, Sachdev VV, Zelcer N, Raabe T, He M, Hand NJ, Drenth JPH, Rader DJ, Stroes ESG, Lefeber DJ, Jonker JW, Holleboom AG.
PMID: 34626841
Cell Mol Gastroenterol Hepatol. 2021 Oct 07; doi: 10.1016/j.jcmgh.2021.09.013. Epub 2021 Oct 07.

BACKGROUND & AIMS: Recently, novel inborn errors of metabolism were identified because of mutations in V-ATPase assembly factors TMEM199 and CCDC115. Patients are characterized by generalized protein glycosylation defects, hypercholesterolemia, and fatty liver disease. Here, we set out to...

Cite
Larsen LE, van den Boogert MAW, Rios-Ocampo WA, et al. Defective Lipid Droplet-Lysosome Interaction Causes Fatty Liver Disease as Evidenced by Human Mutations in TMEM199 and CCDC115. Cell Mol Gastroenterol Hepatol. 2021;doi: 10.1016/j.jcmgh.2021.09.013.
Larsen, L. E., van den Boogert, M. A. W., Rios-Ocampo, W. A., Jansen, J. C., Conlon, D., Chong, P. L. E., Levels, J. H. M., Eilers, R. E., Sachdev, V. V., Zelcer, N., Raabe, T., He, M., Hand, N. J., Drenth, J. P. H., Rader, D. J., Stroes, E. S. G., Lefeber, D. J., Jonker, J. W., & Holleboom, A. G. (2021). Defective Lipid Droplet-Lysosome Interaction Causes Fatty Liver Disease as Evidenced by Human Mutations in TMEM199 and CCDC115. Cellular and molecular gastroenterology and hepatology, . https://doi.org/10.1016/j.jcmgh.2021.09.013
Larsen, Lars E, et al. "Defective Lipid Droplet-Lysosome Interaction Causes Fatty Liver Disease as Evidenced by Human Mutations in TMEM199 and CCDC115." Cellular and molecular gastroenterology and hepatology vol. (2021). doi: https://doi.org/10.1016/j.jcmgh.2021.09.013
Larsen LE, van den Boogert MAW, Rios-Ocampo WA, Jansen JC, Conlon D, Chong PLE, Levels JHM, Eilers RE, Sachdev VV, Zelcer N, Raabe T, He M, Hand NJ, Drenth JPH, Rader DJ, Stroes ESG, Lefeber DJ, Jonker JW, Holleboom AG. Defective Lipid Droplet-Lysosome Interaction Causes Fatty Liver Disease as Evidenced by Human Mutations in TMEM199 and CCDC115. Cell Mol Gastroenterol Hepatol. 2021 Oct 07; doi: 10.1016/j.jcmgh.2021.09.013. Epub 2021 Oct 07. PMID: 34626841.
Copy Download .nbib Format: NLM
Letter to the Editor.

Cartilage

Jansen M, Lafeber F.
PMID: 33100026
Cartilage. 2021 Dec;13(1):1830S-1833S. doi: 10.1177/1947603520966856. Epub 2020 Oct 26.

No abstract available.

Cite
Jansen M, Lafeber F. Letter to the Editor. Cartilage. 2020;13(1):1830S-1833Sdoi: 10.1177/1947603520966856.
Jansen, M., & Lafeber, F. (2021). Letter to the Editor. Cartilage, 13(1), 1830S-1833S. https://doi.org/10.1177/1947603520966856
Jansen, Mylène, and Lafeber, Floris. "Letter to the Editor." Cartilage vol. 13,1 (2021): 1830S-1833S. doi: https://doi.org/10.1177/1947603520966856
Jansen M, Lafeber F. Letter to the Editor. Cartilage. 2021 Dec;13(1):1830S-1833S. doi: 10.1177/1947603520966856. Epub 2020 Oct 26. PMID: 33100026.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 80 entries